Q1 2025 Prestige Consumer Healthcare Inc Earnings Call Transcript
Key Points
- Prestige Consumer Healthcare Inc (PBH) exceeded its sales and earnings expectations for Q1 2025, despite supply chain challenges.
- The company experienced strong international growth, particularly with the Hydralyte brand, contributing to overall performance.
- Free cash flow increased to $54 million, enabling debt reduction and share repurchases, enhancing shareholder value.
- The Hydralyte brand continues to grow at a mid-teens CAGR, with strong market presence in Australia and potential for geographic expansion.
- The company maintained a leverage ratio of 2.8 times, indicating strong financial management and stability.
- Q1 revenue declined by 4.4% compared to the prior year, primarily due to supply chain issues affecting the Clear Eyes product line.
- Gross margin was impacted by higher air freight costs, resulting in a lower margin than forecasted.
- Adjusted EPS decreased to $0.90 from $1.06 in the prior year, affected by lower revenues and increased costs.
- The women's health and cough-cold categories faced continued pressure, impacting overall sales performance.
- The company anticipates ongoing supply chain challenges, particularly in the eye care segment, which may affect future sales timing.
Welcome to the Q1 2025 Prestige Consumer Healthcare, Inc., earnings conference call. (Operator Instructions) Please be advised that today's conference is being recorded.
I would now like to hand the conference over to your first speaker today, Phil Terpolilli, Vice President, Investor Relations and Treasury. Please go ahead.
Thanks, Operator, and thank you to everyone who has joined today. On the call with me are Ron Lombardi, our Chairman, President and CEO; and Christine Sacco, our CFO. On today's call, we'll review our first quarter fiscal 2025 results, discuss the full-year outlook, and then take questions from analysts. A slide presentation accompanies today's call. It can be accessed by visiting prestigeconsumerhealthcare.com, clicking on the Investors link, and then on today's webcast and presentation.
Please remember some of the information contained in the presentation today includes non-GAAP financial measures. Reconciliations to the nearest GAAP financial measures
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
